Standout Papers

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stro... 2015 2026 2018 2022 320
  1. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation (2015)
    A. John Camm, Pierre Amarenco et al. European Heart Journal

Immediate Impact

59 standout
Sub-graph 1 of 20

Citing Papers

Atrial fibrillation burden: a new outcome predictor and therapeutic target
2024 Standout
Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial
2024 Standout
4 intermediate papers

Works of Susanne Hess being referenced

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
2015
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Susanne Hess 789 349 157 14 918
Franziska Michalski 735 520 58 11 798
Luise Tittl 1031 763 109 39 1.1k
Renee M. Sullivan 749 192 112 23 792
Gregory C. Flaker 1004 415 123 20 1.2k
John Doherty 762 439 124 10 919
Frits R. Rosendaal 666 341 123 13 855
Lynn B. Oertel 957 307 126 11 1.1k
R. Hull 591 804 356 15 1.0k
Ramiz Fargo 678 332 84 12 817
Massimo Zoni-Berisso 1007 125 74 11 1.1k

All Works

Loading papers...

Rankless by CCL
2026